EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Monoclonal gammopathy of undetermined significance: predictors of malignant transformation and recognition of an evolving type characterized by a progressive increase in M protein size



Monoclonal gammopathy of undetermined significance: predictors of malignant transformation and recognition of an evolving type characterized by a progressive increase in M protein size



Mayo Clinic Proceedings 82(4): 428-434



OBJECTIVE: To investigate the predictors of monoclonal gammopathy of undetermined significance (MGUS) by considering not only the initial features but also the pattern of evolution of the M protein during the first years after diagnosis.PATIENTS AND METHODS: This study consisted of 359 patients diagnosed as having MGUS at a single institution. Patients who showed a definite and progressive increase in their M protein size according to serum electrophoresis during the first 3 years of follow-up were considered to have evolving MGUS, whereas all others were considered to have nonevolving MGUS.RESULTS: Of the 359 patients, 330 had nonevolving MGUS, whereas 29 fulfilled the criteria for evolving MGUS. Overall, 32 patients developed malignant transformation. The progression rates at 10 and 20 years of follow-up for the evolving and the nonevolving types were 55% vs 3.0% and 80% vs 13%, respectively. Multivariate analysis revealed that the features significantly associated with a higher risk of progression were evolving MGUS (relative risk [RR], 12.3.4;. P<.001), IgA MGUS (RR, 2.93; P=.006), and M protein concentration (RR, 2.18; P=.04).CONCLUSION: The evolutionary pattern of serum M protein (progressive increasing vs stable) during the first years of follow-up is the most important risk factor for disease progression in patients with MGUS.

(PDF emailed within 0-6 h: $19.90)

Accession: 013763487

Download citation: RISBibTeXText

PMID: 17418070

DOI: 10.4065/82.4.428



Related references

The impact of M-component type and immunoglobulin concentration on the risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance. Haematologica 86(11): 1172-1179, 2001

Malignant transformation in IgM monoclonal gammopathy of undetermined significance. Seminars in Oncology 30(2): 178-181, 2003

Malignant transformation of monoclonal gammopathy of undetermined significance. Presse Medicale 36(12 Pt 3): 1985-1996, 2007

Malignant transformation in monoclonal gammopathy of undetermined significance. British Journal of Haematology 87(SUPPL 1): 221, 1994

Prognostic factors in malignant transformation of monoclonal gammopathy of undetermined significance. Leukemia & Lymphoma 43(8): 1713-1714, 2002

Risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance. Biomedicine & Pharmacotherapy 51(2): 74-78, 1997

Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance. British Journal of Haematology 81(3): 391-394, 1992

Malignant transformation in monoclonal gammopathy of undetermined significance Analysis of 847 cases. Blood 88(10 SUPPL 1 PART 1-2): 387A, 1996

Malignant transformation of monoclonal gammopathy of undetermined significance: cumulative incidence and prognostic factors. Leukemia & Lymphoma 42(4): 609-618, 2001

Prognostic indicators in the malignant transformation of monoclonal gammopathy of undetermined significance to primary systemic amyloidosis. Blood 92(10 SUPPL 1 PART 1-2): 268B-269B, Nov 15, 1998

Malignant transformation of monoclonal gammopathy of undetermined significance among out-patients of a community hospital in Southeastern Netherlands. British Journal Of Haematology. 91(1): 121-125, 1995

Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. Journal of Clinical Oncology 20(6): 1625-1634, 2002

Blood clonal B-cell excess in patients with monoclonal gammopathy of undetermined significance (MGUS): association with malignant transformation. British Journal of Haematology 92(1): 71-76, 1996

Monoclonal gammopathy of undetermined significance evolving directly in primary plasma cell leukemia. Biomedicine & PharmacoTherapy 51(6-7): 284-285, 1997